• Media type: E-Article
  • Title: Evaluation of Patient’s Quality of Life before and after Implantation of Abbott’s Proclaim™ XR Spinal Cord Stimulator with BurstDR™ Stimulation in Chronic Pain Syndrome
  • Contributor: Ślusarczyk, Wojciech Tomasz; Nejman, Tadeusz Jerzy; Laskowski, Maciej; Koperczak, Agnieszka; Stanuszek, Agnieszka; Ciekalski, Marcin
  • Published: MDPI AG, 2023
  • Published in: Medicina, 59 (2023) 12, Seite 2192
  • Language: English
  • DOI: 10.3390/medicina59122192
  • ISSN: 1648-9144
  • Origination:
  • Footnote:
  • Description: Background and Objectives: In case of the ineffectiveness of pharmacological and non-pharmacological treatments in managing chronic neuropathic pain, spinal cord stimulation (SCS) with BurstDR™ stimulation may reduce pain and increase the quality of life. The term “burst” refers to a series of stimulation impulses that are compressed into small packets and separated by intervals of latency. Materials and Methods: A group of 30 consecutive patients who received the BurstDR™ stimulator using the minimally invasive percutaneous method was selected. Patients selected for our study underwent numerous spinal surgeries before SCS implantation. In the study, analgesics and co-analgesics and their doses used by patients before and 6 months after SCS implantation were examined and compared. Using the visual analogue scale (VAS), pain was compared before and after the procedure. Patients` quality of life was assessed using the Oswestry Disability Index (ODI). Results: We observed a significant reduction in opioid daily doses by an average of 32.4% (±36.1%) and a reduction in paracetamol daily doses by an average of 40% (±33.4%). There was a reduction in pregabalin doses as well. Ketoprofen daily dose reduction was 85.4 mg. The mean VAS difference before and after procedure was 3.9 (±2.3), and the mean difference in ODI was 12.9 (±9), which benefits operative treatment. The VAS and ODI results were statistically significant as well. Conclusions: According to our research, BurstDR™ stimulation improves the quality of life by reducing doses of analgesics and the level of pain.
  • Access State: Open Access